IHAM
TWST icon

Integral Health Asset Management’s Twist Bioscience TWST Stock Holding History

Integral Health Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,000
Closed -$4.52M – 99
2024
Q3 		$4.52M Buy
+100,000
New +$4.76M 0.51% 47

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Integral Health Asset Management's TWST Position: Q4 2024 in Review

Integral Health Asset Management sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 100,000 shares — an estimated $4.52M sold.

Integral Health Asset Management first reported a position in TWST in Q3 2024 and held it in 1 quarter. The position peaked at $4.52M in Q3 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

  • Integral Health Asset Management reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
  • Integral Health Asset Management sold 100,000 Twist Bioscience shares in Q4 2024, an estimated $4.52M.
  • Integral Health Asset Management first reported a position in Twist Bioscience in Q3 2024 and held it in 1 quarter.
  • Integral Health Asset Management's Twist Bioscience position peaked at $4.52M in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Integral Health Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.